• If you are wondering whether Axon Enterprise at about US$385 a share still makes sense for your portfolio, or if the recent price leaves limited value on the table, this article breaks down what the current valuation signals may be indicating.
• The stock is down 1.8% over the past week, 3.0% over the past month, and 31.6% year to date, leaving the 1 year return 48.4% lower even after 3 year and 5 year gains of 99.5% and 176.9% respectively.
• Recent coverage has focused on Axon Enterprise's role in public safety technology, including its TASER devices and software platforms for law enforcement and justice systems. This context around the business model and its customers helps frame how investors are reacting to the current share price levels.
• Simply Wall St currently gives Axon Enterprise a valuation score of 2 out of 6. Next is a look at the standard valuation checks investors often use, followed by a more complete way to assess whether that score reflects the stock's potential.

Axon Enterprise scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Axon Enterprise Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow (DCF) model takes projections of a company’s future cash flows and discounts them back to today using a required rate of return, giving an estimate of what the business might be worth right now.

For Axon Enterprise, the model used is a 2 Stage Free Cash Flow to Equity approach, built on cash flow projections in $. The latest twelve month free cash flow is about $28.7m. Analyst forecasts and subsequent extrapolations see free cash flow reaching $1,001.2m in 2028, with a sequence of projected cash flows between 2026 and 2035 that are discounted back to present value using Simply Wall St’s assumptions.

Bringing all those discounted cash flows together gives an estimated intrinsic value of about $387.39 per share, compared with a current share price of roughly $385. With an implied discount of around 0.5%, the model suggests Axon Enterprise is priced very close to its estimated fair value right now.

Result: ABOUT RIGHT

Axon Enterprise is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Approach 2: Axon Enterprise Price vs Sales

For profitable companies that are still heavily focused on expanding revenue, the price to sales, or P/S, multiple is a useful way to see how much investors are paying for each dollar of sales, especially when earnings can be influenced by investment in growth or accounting items.

Expectations for future growth and the level of risk usually help shape what looks like a reasonable trading range for any valuation multiple. Higher growth and lower perceived risk often support a higher ratio, while slower growth or higher risk point to a lower one.

Axon Enterprise currently trades on a P/S ratio of about 10.41x. That sits above the Aerospace & Defense industry average P/S of 5.24x and also above the peer average of 7.88x. Simply Wall St’s Fair Ratio for Axon Enterprise is 14.28x, which is the P/S multiple suggested by its model after considering factors such as earnings growth, profit margins, industry, market cap and risk characteristics.

Because the Fair Ratio incorporates these company specific drivers, it can offer a more tailored reference point than a simple comparison with peers or the broad industry. With the current 10.41x P/S below the 14.28x Fair Ratio, the stock screens as undervalued on this metric.

Result: UNDERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Axon Enterprise Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives step in as your way to attach a clear story about Axon Enterprise to the numbers you care about, linking your view of its products, risks and opportunities directly to a financial forecast and then to a fair value that can be compared with the current share price.

On Simply Wall St's Community page, Narratives let you set assumptions for future revenue, earnings and margins, then see what fair value those inputs imply. This allows you to quickly judge whether Axon Enterprise looks expensive or attractive relative to your own expectations rather than only to standard ratios.

Narratives update automatically when fresh information such as news or earnings is added to the platform, so your fair value view stays aligned with the latest data instead of relying on a static model that can go stale.

For example, one Axon Enterprise Narrative might focus on the software and data platform story with a Fair Value of about US$606.83 per share. Another might lean into a more cautious view with a Fair Value close to US$420.19, or a more optimistic view around US$925.00. Comparing those figures with the current price helps you decide which story, and which assumptions, you find most reasonable for your own decision making.

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.